It has been proposed that the acute development of low FT3 levels following severe illnesses, including patients with acute cardiac events; after brain tumor surgery and patients with respiratory failure [26–28], occurs due to the induction of decreased peripheral conversion of FT4 to FT3 and aberrant thyroid hormone metabolism in CNS [29, 30]. The gene discussed is TG; the disease is brain neoplasm.